Nu Skin Enterprises (NUS) 10-Q 7 May 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 01, 2020
Cover [Abstract]
Entity Registrant Name	NU SKIN ENTERPRISES, INC.
Entity Central Index Key	0001021561
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		51,899,031
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-12421
Entity Tax Identification Number	87-0565309
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	75 West Center Street
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84601
City Area Code	801
Local Phone Number	345-1000
Title of 12(b) Security	Class A Common Stock, $.001 par value
Trading Symbol	NUS
Security Exchange Name	NYSE

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 352,578	$ 335,630
Current investments	9,087	8,413
Accounts receivable, net	43,973	50,378
Inventories, net	257,474	275,891
Prepaid expenses and other	66,457	69,854
Total current assets	729,569	740,166
Property and equipment, net	449,486	453,604
Right-of-use assets	147,678	144,326
Goodwill	196,573	196,573
Other intangible assets, net	77,796	80,321
Other assets	145,217	154,016
Total assets	1,746,319	1,769,006
Current liabilities:
Accounts payable	39,891	38,979
Accrued expenses	285,213	290,281
Current portion of long-term debt	95,000	27,500
Total current liabilities	420,104	356,760
Operating lease liabilities	108,145	105,701
Long-term debt	327,197	334,461
Other liabilities	90,375	96,795
Total liabilities	945,821	893,717
Commitments and contingencies (Note 10)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	557,916	557,544
Treasury stock, at cost - 37.5 million and 35.0 million shares	(1,384,036)	(1,324,826)
Accumulated other comprehensive loss	(100,289)	(85,292)
Retained earnings	1,726,816	1,727,772
Total stockholders' equity	800,498	875,289
Total liabilities and stockholders' equity	$ 1,746,319	$ 1,769,006

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions	Mar. 31, 2020	Dec. 31, 2019
Stockholders' equity:
Common stock, shares authorized (in shares)	500	500
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	37.5	35

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Consolidated Statements of Income (Unaudited) [Abstract]
Revenue	$ 518,028	$ 623,623
Cost of sales	125,793	146,664
Gross profit	392,235	476,959
Operating expenses:
Selling expenses	206,042	249,708
General and administrative expenses	149,628	158,598
Total operating expenses	355,670	408,306
Operating income	36,565	68,653
Other income (expense), net	(6,174)	(2,848)
Income before provision for income taxes	30,391	65,805
Provision for income taxes	10,661	22,803
Net income	$ 19,730	$ 43,002
Net income per share (Note 6):
Basic (in dollars per share)	$ 0.36	$ 0.78
Diluted (in dollars per share)	$ 0.36	$ 0.77
Weighted-average common shares outstanding:
Basic (in shares)	55,059	55,436
Diluted (in shares)	55,101	56,128

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net income	$ 19,730	$ 43,002
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustment, net of taxes of $(3) and $(145) for the three months ended March 31, 2020 and 2019, respectively	(14,997)	4,140
Comprehensive income	$ 4,733	$ 47,142

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Other comprehensive income, net of tax:
Foreign currency translation adjustment, tax	$ (3)	$ (145)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]Class A [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Stockholders' Equity [Roll Forward]
Cumulative effect adjustment from adoption of ASC Topic | ASC Topic 842 [Member]	$ 0	$ 0	$ 0	$ 0	$ 657	$ 657
Balance at beginning of period at Dec. 31, 2018	91	552,564	(1,326,605)	(79,934)	1,635,751	781,867
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	43,002	43,002
Other comprehensive (loss) income, net of tax	0	0	0	4,140	0	4,140
Repurchase of Class A common stock (Note 6)	0	0	(825)	0	0	(825)
Exercise of employee stock options/vesting of stock awards	0	(4,335)	2,179	0	0	(2,156)
Stock-based compensation	0	5,041	0	0	0	5,041
Cash dividends	0	0	0	0	(20,531)	(20,531)
Balance at end of period at Mar. 31, 2019	91	553,270	(1,325,251)	(75,794)	1,658,879	811,195
Balance at beginning of period at Dec. 31, 2019	91	557,544	(1,324,826)	(85,292)	1,727,772	875,289
Stockholders' Equity [Roll Forward]
Net income	0	0	0	0	19,730	19,730
Other comprehensive (loss) income, net of tax	0	0	0	(14,997)	0	(14,997)
Repurchase of Class A common stock (Note 6)	0	0	(60,886)	0	0	(60,886)
Exercise of employee stock options/vesting of stock awards	0	(3,083)	1,676	0	0	(1,407)
Stock-based compensation	0	3,455	0	0	0	3,455
Cash dividends	0	0	0	0	(20,686)	(20,686)
Balance at end of period at Mar. 31, 2020	$ 91	$ 557,916	$ (1,384,036)	$ (100,289)	$ 1,726,816	$ 800,498

Consolidated Statements of St_2

Consolidated Statements of Stockholder's Equity (Unaudited) (Parenthetical) - shares shares in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Stockholders' Equity [Roll Forward]
Exercise of employee stock options (in shares)	0.1	0.2

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ 19,730	$ 43,002
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	19,095	19,607
Foreign currency losses	3,177	458
Stock-based compensation	3,455	5,041
Loss on disposal of assets	2,286	0
Deferred taxes	963	1,668
Non-cash lease expense	10,869	11,375
Changes in operating assets and liabilities:
Accounts receivable	5,081	(4,145)
Inventories, net	10,764	(7,271)
Prepaid expenses and other	965	(15,540)
Other assets	(24,905)	(180)
Accounts payable	1,491	5,157
Accrued expenses	12,889	(68,842)
Other liabilities	3,167	1,484
Net cash provided by (used in) operating activities	69,027	(8,186)
Cash flows from investing activities:
Purchases of property and equipment	(19,387)	(13,765)
Proceeds on investment sales	4,234	7,444
Purchases of investments	(4,031)	(4,321)
Acquisitions and investments in equity investees	0	(7,500)
Net cash used in investing activities	(19,184)	(18,142)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	(1,407)	(2,156)
Payments on long-term debt	(5,000)	(134,455)
Payment of cash dividends	(20,686)	(20,531)
Proceeds from debt	65,000	105,000
Repurchases of shares of common stock	(60,886)	(825)
Net cash used in financing activities	(22,979)	(52,967)
Effect of exchange rate changes on cash	(9,916)	2,672
Net increase (decrease) in cash and cash equivalents	16,948	(76,623)
Cash and cash equivalents, beginning of period	335,630	386,911
Cash and cash equivalents, end of period	$ 352,578	$ 310,288

The Company

The Company	3 Months Ended
	Mar. 31, 2020
The Company [Abstract]
The Company	1. The Company Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin, a leading global direct selling company, being the primary operating unit. Nu Skin develops and distributes premium-quality, innovative personal care products and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services. The Company reports revenue from segments, consisting of its geographic Nu Skin segments — Mainland China; South Korea; Southeast Asia, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand and Vietnam; Americas/Pacific, which includes Australia, Canada, Latin America, New Zealand and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa (“EMEA”), which includes several markets in Europe as well as Israel, Russia and South Africa —its Manufacturing segment, which includes manufacturing and packaging subsidiaries; and its (the Company’s subsidiaries operating within each segment are collectively referred to as the “Subsidiaries”).

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information as of March 31, 2020, and for the three-month periods ended March 31, 2020 and 2019. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December 31, 2019 has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Additionally, based on the duration and severity of the novel coronavirus (“COVID-19”) pandemic, including but not limited to limitations of holding sales meetings, supply chain disruptions, reduced travel and closed walk-in locations, the Company is uncertain of the ultimate impact COVID-19 could have on the business. To date, the pandemic has not increased the Company’s costs of or access to capital under the revolving credit facility, and at this time cannot provide assurance it won’t in the future. This uncertainty could have an impact in future periods on certain estimates used in the preparation of the first quarter financial results, including, but not limited to impairment of goodwill and other long-lived assets, income tax provision and recoverability of inventory. Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . This guidance modifies the measurement of expected credit losses of certain financial instruments. This ASU is effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods and should be applied on a modified retrospective basis to all periods presented. This ASU was effective for the Company beginning on January 1, 2020. The adoption of the new standard did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU was effective for the Company beginning on January The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal-Use Software Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract he Company adopted this standard prospectively on January The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. Inventory Inventories consist of the following (U.S. dollars in thousands): March 31, 2020 December 31, 2019 Raw materials $ 85,167 $ 87,942 Finished goods 172,307 187,949 Total Inventory, net $ 257,474 $ 275,891 Revenue Recognition Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products on an annual basis. The balance of deferred revenue related to contract liabilities as of March 31, 2020 and December 31, 2019 was $11.9 million and $12.5 million, respectively.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2020
Goodwill [Abstract]
Goodwill	3. Goodwill The Company’s reporting units for goodwill are its operating segments, which are also its reportable segments. The following table presents goodwill allocated to the Company’s reportable segments for the periods ended March 31, 2020 and December 31, 2019 (U.S. dollars in thousands): March 31, 2020 December 31, 2019 Nu Skin Mainland China $ 32,179 $ 32,179 South Korea 29,261 29,261 Americas/Pacific 9,449 9,449 Southeast Asia 18,537 18,537 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 EMEA 2,875 2,875 Manufacturing 72,469 72,469 Grow Tech 9,150 9,150 Total $ 196,573 $ 196,573

Debt

Debt	3 Months Ended
	Mar. 31, 2020
Debt [Abstract]
Debt	4. Debt Credit Agreement On April 18, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent. The Credit Agreement provides for a $400 million term loan facility and a $350 million revolving credit facility, each with a term of five years. Both facilities bear interest at the London Interbank Offered Rate (“LIBOR”), plus a margin based on the consolidated leverage ratio. The term loan facility amortizes in quarterly installments in amounts resulting in an annual amortization of 5.0% during the first and second years, 7.5% during the third and fourth years and 10.0% during the fifth year after the closing date of the Credit Agreement, with the remainder payable at final maturity. The Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. As of March 31, 2020, the Company was in compliance with all covenants under the Credit Agreement. The following table summarizes the Company’s debt facilities as of March 31, 2020 and December 31, 2019: Facility or Arrangement Original Principal Amount Balance as of March 31 , 2020 (1)(2) Balance as of December 31 , 2019 (2) Interest Rate Repayment Terms Credit Agreement term loan facility $ 400.0 million $ 360.0 million $ 365.0 million Variable 35% of the principal amount is payable Credit Agreement revolving credit facility $ 65.0 million $ — Variable Revolving line of credit expires April 18, 2023. (1) As of March 31, 2020, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $ million of the balance of its term loan under the Credit Agreement. . (2) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $2.8 million and $ million as of March 31, 2020 and December 31, 2019, respectively, related to the Credit Agreement, which are not reflected in this table.

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	5. Leases The Company has operating and finance leases for regional offices, manufacturing facilities, retail centers, distribution centers and certain equipment. The Company’s leases have remaining lease terms of 1 year to 24 years, some of which include options to extend the leases for up to 20 years, and some of which include options to terminate the leases within 1 year. As of March 31, 2020, the weighted average remaining lease term and weighted average discount rate for operating leases was 6.4 years and 4.8%. The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended March 31, 2020 2019 Operating lease cost $ 13,136 $ 12,861 Variable lease cost 974 1,052 Short-term lease cost 45 52 Sublease income (1,131 ) (1,593 ) Total lease expense $ 13,024 $ 12,372 Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Three Months Ended March 31, 2020 2019 Operating cash outflow from operating leases $ 13,367 $ 14,377 Right-of-use assets obtained in exchange for lease obligations $ 21,822 $ 128,704 Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31, Operating Leases 2020 $ 37,395 2021 43,231 2022 28,941 2023 20,119 2024 15,597 Thereafter 30,881 Total 176,164 Less: Finance charges 27,563 Total principal liability $ 148,601 The Company has additional lease liabilities of $0.1 million which have not yet commenced as of March 31, 2020, and as such, have not been recognized on the consolidated balance sheets.

Capital Stock

Capital Stock	3 Months Ended
	Mar. 31, 2020
Capital Stock [Abstract]
Capital Stock	6. Capital Stock Net income per share Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended March 31, 2020 and 2019, stock options of 1.0 million and 1.0 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive. Dividends In February 2020 , the Company’s board of directors declared a quarterly cash dividend of $ per share. This quarterly cash dividend of $ million was paid on to stockholders of record on . April 2020 Repurchase of common stock During the three-month periods ended March 31, 2020 and 2019, the Company repurchased shares of its Class A common stock under its stock repurchase plan for $ million and $ million, respectively. As of March 31, 2020, $ million was available for repurchases under the Company’s stock repurchase plan.

Fair Value

Fair Value	3 Months Ended
	Mar. 31, 2020
Fair Value [Abstract]
Fair Value	7. Fair Value The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximate fair values due to the short-term nature of these instruments. Fair value estimates are made at a specific point in time, based on relevant market information. The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy: ◾ Level 1 – quoted prices in active markets for identical assets or liabilities; ◾ Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; ◾ Level 3 – unobservable inputs based on the Company’s own assumptions. Accounting standards permit companies, at their option, to measure certain financial instruments and other eligible items at fair value. The Company has elected not to apply the fair value option to existing eligible items beyond what is required by US GAAP. The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at March 31, 2020 Level 1 Level 2 Level 3 Total Financial assets: Cash equivalents and current investments $ 49,670 $ — $ — $ 49,670 Other long-term assets 202 — — 202 Life insurance contracts — — 35,339 35,339 Total $ 49,872 $ — $ 35,339 $ 85,211 Fair Value at December 31, 2019 Level 1 Level 2 Level 3 Total Financial assets: Cash equivalents and current investments $ 54,642 $ — $ — $ 54,642 Other long-term assets 3,216 — — 3,216 Life insurance contracts — — 41,707 41,707 Total $ 57,858 $ — $ 41,707 $ 99,565 The following table provides a summary of changes in fair value of the Company’s Level 3 marketable securities (U.S. dollars in thousands): Beginning balance at January 1, 2020 $ 41,707 Actual return on plan assets (6,368 ) Purchase and issuances — Sales and settlements — Transfers into Level 3 — Ending balance at March 31, 2020 $ 35,339

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Taxes [Abstract]
Income Taxes	8. Income Taxes Provision for income taxes for the first quarter of 2020 was $10.7 million, compared to $22.8 million for the prior-year period. The effective tax rate for the first quarter of 2020 was 35.1% of pre-tax book income, compared to 34.7% in the prior-year period. The Company accounts for income taxes in accordance with ASC Topic 740 “Income Taxes.” These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. The Company had net deferred tax assets of $19.5 million and $20.0 million as of March 31, 2020 and December 31, 2019, respectively. The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. For all foreign earnings, the Company accrues the applicable foreign income taxes. For the earnings that have been indefinitely reinvested, the Company does not accrue foreign withholding taxes. Undistributed earnings that the Company has indefinitely reinvested, for which no foreign withholding taxes have been provided, aggregate to $60.0 million as of December 31, 2019. If the amount designated as indefinitely reinvested as of December 31, 2019 was repatriated to the United States, the amount of incremental taxes would be approximately $6.0 million. The Company intends to utilize the indefinitely reinvested offshore earnings to fund foreign investments, specifically capital expenditures. The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. The Company is no longer subject to tax examinations from the IRS for all years for which tax returns have been filed before 2015. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2015. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. The Company has elected to participate in CAP for 2020 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. In major foreign jurisdictions, the Company is generally no longer subject to income tax examinations for years before 2012. However, statutes of limitations in certain countries may be as long as ten years. The Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable. The Company’s unrecognized tax benefits relate to multiple jurisdictions. Due to potential decreases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitations, it is reasonably possible that the Company’s gross unrecognized tax benefits, net of foreign currency adjustments, may decrease in the next 12 months by approximately $0.5 to $1.5 million.

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2020
Segment Information [Abstract]
Segment Information	9. Segment Information The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments—Mainland China, South Korea, Southeast Asia, Americas/Pacific, Japan, Hong Kong/Taiwan, and EMEA—and its Manufacturing and Grow Tech segments. The Other category includes miscellaneous corporate revenue and related adjustments. These segments reflect the way the chief operating decision maker evaluates the Company’s business performance and allocates resources. Reported revenue includes only the revenue generated by sales to external customers. Profitability by segment as determined under US GAAP is driven primarily by the Company’s transfer pricing policies. Segment contribution, which is the Company’s segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company’s executive and administrative offices, information technology, research and development, and marketing and supply chain functions not recorded at the segment level. The accounting policies of the segments are the same as those described in Note 2 – Summary of Significant Accounting Policies. The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations. Summarized financial information for the Company’s reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company’s internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment. Revenue by Segment Three Months Ended March 31, (U.S. dollars in thousands) 2020 2019 Nu Skin Mainland China $ 137,696 $ 208,488 South Korea 75,719 83,853 Americas/Pacific 74,573 86,456 Southeast Asia 69,586 72,495 Japan 61,300 62,109 Hong Kong/Taiwan 35,827 40,558 EMEA 35,403 41,818 Other 773 (1,426 ) Total Nu Skin 490,877 594,351 Manufacturing (1) 27,147 29,272 Grow Tech 4 — Total $ 518,028 $ 623,623 (1) The Manufacturing segment had $6.4 million and $5.9 million of intersegment revenue for the three-month period ended March 31, 2020 and 2019, respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above. Segment Contribution Three Months Ended March 31, (U.S. dollars in thousands) 2020 2019 Nu Skin Mainland China $ 37,387 $ 59,167 South Korea 24,099 25,668 Americas/Pacific 10,585 12,019 Southeast Asia 16,718 17,992 Japan 14,592 14,106 Hong Kong/Taiwan 6,938 7,474 EMEA 631 1,351 Nu Skin contribution 110,950 137,777 Manufacturing 2,849 3,646 Grow Tech (6,850 ) (3,629 ) Total segment contribution 106,949 137,794 Corporate and other (70,384 ) (69,141 ) Operating income 36,565 68,653 Other income (expense) (6,174 ) (2,848 ) Income before provision for income taxes $ 30,391 $ 65,805 Depreciation and Amortization Three Months Ended March 31, (U.S. dollars in thousands) 2020 2019 Nu Skin Mainland China $ 2,424 $ 3,116 South Korea 1,057 1,524 Americas/Pacific 245 214 Southeast Asia 487 477 Japan 472 1,048 Hong Kong/Taiwan 639 516 EMEA 258 440 Total Nu Skin 5,582 7,335 Manufacturing 1,815 1,574 Grow Tech 1,225 875 Corporate and other 10,473 9,823 Total $ 19,095 $ 19,607 Capital Expenditures Three Months Ended March 31, (U.S. dollars in thousands) 2020 2019 Nu Skin Mainland China $ 2,861 $ 1,681 South Korea 169 49 Americas/Pacific 694 274 Southeast Asia 633 94 Japan 157 172 Hong Kong/Taiwan 4 463 EMEA 27 34 Total Nu Skin 4,545 2,767 Manufacturing 10,505 1,602 Grow Tech 178 2,985 Corporate and other 4,159 6,411 Total $ 19,387 $ 13,765

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies [Abstract]
Commitments and Contingencies	10. Commitments and Contingencies The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company’s sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. Management believes that the ultimate liability arising from such claims and contingencies, if any, is not likely to have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows. The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company’s reserves, which would impact its reported financial results.

Restructuring

Restructuring	3 Months Ended
	Mar. 31, 2020
Restructuring [Abstract]
Restructuring	11. Restructuring In the fourth quarter of 2018, the Company began a strategic plan to align its resources and capabilities to support its vision of being a world-leading business platform. This program primarily impacted the Company’s information technology infrastructure and organization and other departments within its corporate and Americas offices. As a result of the restructuring program, the Company recorded a non-cash charge of $ million for impairment of information technology assets, including internally developed software for social sharing and digital initiatives, and $ million of cash charges, including $ million for employee severance and $ million for other related cash charges with the restructuring. The restructuring charges were predominately recorded in the Corporate and Other category. See the table below for detail of restructuring activity for the three months ended March 31, 2019 (U.S. dollars in thousands): Beginning balance at January 1, 2019 $ 15,462 Amounts paid (15,046 ) Adjustments (416 ) Ending balance at March 31, 2019 $ — There was no restructuring activity for the three months ended March 31, 2020.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Summary of Significant Accounting Policies [Abstract]
Basis of Accounting	The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information as of March 31, 2020, and for the three-month periods ended March 31, 2020 and 2019. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December 31, 2019 has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Additionally, based on the duration and severity of the novel coronavirus (“COVID-19”) pandemic, including but not limited to limitations of holding sales meetings, supply chain disruptions, reduced travel and closed walk-in locations, the Company is uncertain of the ultimate impact COVID-19 could have on the business. To date, the pandemic has not increased the Company’s costs of or access to capital under the revolving credit facility, and at this time cannot provide assurance it won’t in the future. This uncertainty could have an impact in future periods on certain estimates used in the preparation of the first quarter financial results, including, but not limited to impairment of goodwill and other long-lived assets, income tax provision and recoverability of inventory.
Accounting Pronouncements	Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . This guidance modifies the measurement of expected credit losses of certain financial instruments. This ASU is effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods and should be applied on a modified retrospective basis to all periods presented. This ASU was effective for the Company beginning on January 1, 2020. The adoption of the new standard did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. This ASU was effective for the Company beginning on January The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. In August 2018, the FASB issued ASU 2018-15, Intangibles-Goodwill and Other-Internal-Use Software Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract he Company adopted this standard prospectively on January The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.
Inventory	Inventory Inventories consist of the following (U.S. dollars in thousands): March 31, 2020 December 31, 2019 Raw materials $ 85,167 $ 87,942 Finished goods 172,307 187,949 Total Inventory, net $ 257,474 $ 275,891
Revenue Recognition	Revenue Recognition Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products on an annual basis. The balance of deferred revenue related to contract liabilities as of March 31, 2020 and December 31, 2019 was $11.9 million and $12.5 million, respectively.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Summary of Significant Accounting Policies [Abstract]
Inventories	Inventories consist of the following (U.S. dollars in thousands): March 31, 2020 December 31, 2019 Raw materials $ 85,167 $ 87,942 Finished goods 172,307 187,949 Total Inventory, net $ 257,474 $ 275,891

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill [Abstract]
Goodwill	The following table presents goodwill allocated to the Company’s reportable segments for the periods ended March 31, 2020 and December 31, 2019 (U.S. dollars in thousands): March 31, 2020 December 31, 2019 Nu Skin Mainland China $ 32,179 $ 32,179 South Korea 29,261 29,261 Americas/Pacific 9,449 9,449 Southeast Asia 18,537 18,537 Japan 16,019 16,019 Hong Kong/Taiwan 6,634 6,634 EMEA 2,875 2,875 Manufacturing 72,469 72,469 Grow Tech 9,150 9,150 Total $ 196,573 $ 196,573

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2020
Debt [Abstract]
Debt Facilities	The following table summarizes the Company’s debt facilities as of March 31, 2020 and December 31, 2019: Facility or Arrangement Original Principal Amount Balance as of March 31 , 2020 (1)(2) Balance as of December 31 , 2019 (2) Interest Rate Repayment Terms Credit Agreement term loan facility $ 400.0 million $ 360.0 million $ 365.0 million Variable 35% of the principal amount is payable Credit Agreement revolving credit facility $ 65.0 million $ — Variable Revolving line of credit expires April 18, 2023. (1) As of March 31, 2020, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $ million of the balance of its term loan under the Credit Agreement. . (2) The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $2.8 million and $ million as of March 31, 2020 and December 31, 2019, respectively, related to the Credit Agreement, which are not reflected in this table.

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Components of Lease Expense	The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended March 31, 2020 2019 Operating lease cost $ 13,136 $ 12,861 Variable lease cost 974 1,052 Short-term lease cost 45 52 Sublease income (1,131 ) (1,593 ) Total lease expense $ 13,024 $ 12,372
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Three Months Ended March 31, 2020 2019 Operating cash outflow from operating leases $ 13,367 $ 14,377 Right-of-use assets obtained in exchange for lease obligations $ 21,822 $ 128,704
Maturities of Operating Lease Liabilities	Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31, Operating Leases 2020 $ 37,395 2021 43,231 2022 28,941 2023 20,119 2024 15,597 Thereafter 30,881 Total 176,164 Less: Finance charges 27,563 Total principal liability $ 148,601

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value [Abstract]
Assets Measured at Fair Value on a Recurring Basis	The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at March 31, 2020 Level 1 Level 2 Level 3 Total Financial assets: Cash equivalents and current investments $ 49,670 $ — $ — $ 49,670 Other long-term assets 202 — — 202 Life insurance contracts — — 35,339 35,339 Total $ 49,872 $ — $ 35,339 $ 85,211 Fair Value at December 31, 2019 Level 1 Level 2 Level 3 Total Financial assets: Cash equivalents and current investments $ 54,642 $ — $ — $ 54,642 Other long-term assets 3,216 — — 3,216 Life insurance contracts — — 41,707 41,707 Total $ 57,858 $ — $ 41,707 $ 99,565
Changes in Fair Value of Level 3 Marketable Securities	The following table provides a summary of changes in fair value of the Company’s Level 3 marketable securities (U.S. dollars in thousands): Beginning balance at January 1, 2020 $ 41,707 Actual return on plan assets (6,368 ) Purchase and issuances — Sales and settlements — Transfers into Level 3 — Ending balance at March 31, 2020 $ 35,339

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Information [Abstract]
Revenue by Segment	Revenue by Segment Three Months Ended March 31, (U.S. dollars in thousands) 2020 2019 Nu Skin Mainland China $ 137,696 $ 208,488 South Korea 75,719 83,853 Americas/Pacific 74,573 86,456 Southeast Asia 69,586 72,495 Japan 61,300 62,109 Hong Kong/Taiwan 35,827 40,558 EMEA 35,403 41,818 Other 773 (1,426 ) Total Nu Skin 490,877 594,351 Manufacturing (1) 27,147 29,272 Grow Tech 4 — Total $ 518,028 $ 623,623 (1) The Manufacturing segment had $6.4 million and $5.9 million of intersegment revenue for the three-month period ended March 31, 2020 and 2019, respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above.
Segment Contribution	Segment Contribution Three Months Ended March 31, (U.S. dollars in thousands) 2020 2019 Nu Skin Mainland China $ 37,387 $ 59,167 South Korea 24,099 25,668 Americas/Pacific 10,585 12,019 Southeast Asia 16,718 17,992 Japan 14,592 14,106 Hong Kong/Taiwan 6,938 7,474 EMEA 631 1,351 Nu Skin contribution 110,950 137,777 Manufacturing 2,849 3,646 Grow Tech (6,850 ) (3,629 ) Total segment contribution 106,949 137,794 Corporate and other (70,384 ) (69,141 ) Operating income 36,565 68,653 Other income (expense) (6,174 ) (2,848 ) Income before provision for income taxes $ 30,391 $ 65,805
Depreciation and Amortization and Capital Expenditures	Depreciation and Amortization Three Months Ended March 31, (U.S. dollars in thousands) 2020 2019 Nu Skin Mainland China $ 2,424 $ 3,116 South Korea 1,057 1,524 Americas/Pacific 245 214 Southeast Asia 487 477 Japan 472 1,048 Hong Kong/Taiwan 639 516 EMEA 258 440 Total Nu Skin 5,582 7,335 Manufacturing 1,815 1,574 Grow Tech 1,225 875 Corporate and other 10,473 9,823 Total $ 19,095 $ 19,607 Capital Expenditures Three Months Ended March 31, (U.S. dollars in thousands) 2020 2019 Nu Skin Mainland China $ 2,861 $ 1,681 South Korea 169 49 Americas/Pacific 694 274 Southeast Asia 633 94 Japan 157 172 Hong Kong/Taiwan 4 463 EMEA 27 34 Total Nu Skin 4,545 2,767 Manufacturing 10,505 1,602 Grow Tech 178 2,985 Corporate and other 4,159 6,411 Total $ 19,387 $ 13,765

Restructuring (Tables)

Restructuring (Tables)	3 Months Ended
	Mar. 31, 2020
Restructuring [Abstract]
Restructuring Activity	See the table below for detail of restructuring activity for the three months ended March 31, 2019 (U.S. dollars in thousands): Beginning balance at January 1, 2019 $ 15,462 Amounts paid (15,046 ) Adjustments (416 ) Ending balance at March 31, 2019 $ —

The Company (Details)

The Company (Details)	3 Months Ended
	Mar. 31, 2020Segment
The Company [Abstract]
Number of reportable segments	9
Number of geographic segments	7

Summary of Significant Accoun_4

Summary of Significant Accounting Policies, Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Inventories [Abstract]
Raw materials	$ 85,167	$ 87,942
Finished goods	172,307	187,949
Total Inventory, net	$ 257,474	$ 275,891

Summary of Significant Accoun_5

Summary of Significant Accounting Policies, Revenue Recognition (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs	$ 11.9	$ 12.5

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Goodwill [Abstract]
Goodwill	$ 196,573	$ 196,573
Nu Skin [Member] | Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179
Nu Skin [Member] | South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261
Nu Skin [Member] | Americas/Pacific [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449
Nu Skin [Member] | Southeast Asia [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537
Nu Skin [Member] | Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019
Nu Skin [Member] | Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634
Nu Skin [Member] | EMEA [Member]
Goodwill [Abstract]
Goodwill	2,875	2,875
Manufacturing [Member]
Goodwill [Abstract]
Goodwill	72,469	72,469
Grow Tech [Member]
Goodwill [Abstract]
Goodwill	$ 9,150	$ 9,150

Debt, Credit Agreement (Details

Debt, Credit Agreement (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Apr. 18, 2018
Credit Agreement [Member] | Maximum [Member]
Debt [Abstract]
Consolidated leverage ratio	2.25
Credit Agreement [Member] | Minimum [Member]
Debt [Abstract]
Consolidated interest coverage ratio	3
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400	$ 400
Term of loan	5 years
Term Loan Facility [Member] | First Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] | Second Year [Member]
Debt [Abstract]
Annual amortization percentage	5.00%
Term Loan Facility [Member] | Third Year [Member]
Debt [Abstract]
Annual amortization percentage	7.50%
Term Loan Facility [Member] | Fourth Year [Member]
Debt [Abstract]
Annual amortization percentage	7.50%
Term Loan Facility [Member] | Fifth Year [Member]
Debt [Abstract]
Annual amortization percentage	10.00%
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity		$ 350
Term of loan	5 years

Debt, Debt Facilities (Details)

Debt, Debt Facilities (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2020		Dec. 31, 2019		Apr. 18, 2018
Debt [Abstract]
Current portion of long-term debt		$ 95,000		$ 27,500
Credit Agreement [Member]
Debt [Abstract]
Unamortized debt issuance costs		2,800		3,000
Credit Agreement Term Loan Facility [Member]
Debt [Abstract]
Original principal amount		400,000				$ 400,000
Balance	[2]	$ 360,000	[1]	365,000
Interest rate		Variable 30 day: 2.74%
Interest rate		2.74%
Term of variable rate		30 days
Repayment terms		35% of the principal amount is payable in increasing quarterly installments over a five-year period that began on June 30, 2018, with the remainder payable at the end of the five-year term.
Percentage of principal payable in installments		35.00%
Term of loan		5 years
Current portion of long-term debt		$ 30,000
Credit Agreement Revolving Credit Facility [Member]
Debt [Abstract]
Balance		$ 65,000		$ 0	[2]
Interest rate		Variable 30 day: 2.68%
Interest rate		2.68%
Term of variable rate		30 days
Repayment terms		Revolving line of credit expires April 18, 2023.
Term of loan		5 years
[1]	As of March 31, 2020, the current portion of the Company’s debt (i.e. becoming due in the next 12 months) included $30.0 million of the balance of its term loan under the Credit Agreement. The Company has classified the $65.0 million borrowed under the revolving line of credit as short term because it is the Company’s intention to use the line of credit to borrow and pay back funds over short periods of time.
[2]	The carrying value of the debt reflects the amounts stated in the above table less debt issuance costs of $2.8 million and $3.0 million as of March 31, 2020 and December 31, 2019, respectively, related to the Credit Agreement, which are not reflected in this table.

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Weighted average remaining lease term for operating leases	6 years 4 months 24 days
Weighted average discount rate for operating leases	4.80%
Components of Lease Expense [Abstract]
Operating lease cost	$ 13,136	$ 12,861
Variable lease cost	974	1,052
Short-term lease cost	45	52
Sublease income	(1,131)	(1,593)
Total lease expense	13,024	12,372
Supplemental Cash Flow Information Related to Leases [Abstract]
Operating cash outflow from operating leases	13,367	14,377
Right-of-use assets obtained in exchange for lease liabilities	21,822	$ 128,704
Maturities of Operating Lease Liabilities [Abstract]
2020	37,395
2021	43,231
2022	28,941
2023	20,119
2024	15,597
Thereafter	30,881
Total	176,164
Less: Imputed interest	27,563
Total lease liability	148,601
Additional lease liabilities not yet commenced	$ 100
Minimum [Member]
Leases [Abstract]
Remaining lease terms	1 year
Maximum [Member]
Leases [Abstract]
Remaining lease terms	24 years
Extension period for leases	20 years
Termination period for leases	1 year

Capital Stock (Details)

Capital Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	Mar. 11, 2020	Apr. 30, 2020	Feb. 29, 2020	Mar. 31, 2020	Mar. 31, 2019
Dividends per Share [Abstract]
Payment of cash dividends				$ 20,686	$ 20,531
Repurchases of Common Stock [Abstract]
Class A common stock repurchased				60,886	$ 825
Amount available for repurchases				$ 409,300
Treasury Stock [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased (in shares)				2,600,000	14,000
Class A common stock repurchased				$ 60,886	$ 825
Dividend Declared 2020-Q1 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared				2020-02
Dividend payable per share (in dollars per share)			$ 0.375
Payment of cash dividends	$ 20,700
Dividend payable, date paid				Mar. 11, 2020
Dividend payable, date of record				Feb. 28, 2020
Dividend Declared 2020-Q2 [Member] | Subsequent Event [Member]
Dividends per Share [Abstract]
Dividend payable, date declared		2020-04
Dividend payable per share (in dollars per share)		$ 0.375
Dividend payable, date paid		Jun. 10, 2020
Dividend payable, date of record		May 29, 2020
Stock Options [Member]
Net Income per Share [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)				1,000,000	1,000,000

Fair Value (Details)

Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Fair Value on a Recurring Basis [Member]
Financial Assets [Abstract]
Cash equivalents and current investments	$ 49,670	$ 54,642
Other long-term assets	202	3,216
Life insurance contracts	35,339	41,707
Financial assets	85,211	99,565
Fair Value on a Recurring Basis [Member] | Level 1 [Member]
Financial Assets [Abstract]
Cash equivalents and current investments	49,670	54,642
Other long-term assets	202	3,216
Life insurance contracts	0	0
Financial assets	49,872	57,858
Fair Value on a Recurring Basis [Member] | Level 2 [Member]
Financial Assets [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Life insurance contracts	0	0
Financial assets	0	0
Fair Value on a Recurring Basis [Member] | Level 3 [Member]
Financial Assets [Abstract]
Cash equivalents and current investments	0	0
Other long-term assets	0	0
Life insurance contracts	35,339	41,707
Financial assets	35,339	$ 41,707
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	41,707
Actual return on plan assets	(6,368)
Purchases and issuances	0
Sales and settlements	0
Transfers into Level 3	0
Ending balance	$ 35,339

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Income Taxes [Abstract]
Provision for income taxes	$ 10,661	$ 22,803
Effective tax rate	35.10%	34.70%
Net deferred tax assets	$ 19,500		$ 20,000
Undistributed earnings of non-U.S. subsidiaries			60,000
Incremental taxes if undistributed earnings on non-U.S. subsidiaries were repatriated			$ 6,000
Minimum [Member]
Income Taxes [Abstract]
Decrease in unrecognized tax benefits within the next 12 months that is reasonably possible	$ (500)
Maximum [Member]
Income Taxes [Abstract]
Statute of limitations related to income tax examinations	10 years
Income Taxes [Abstract]
Decrease in unrecognized tax benefits within the next 12 months that is reasonably possible	$ (1,500)

Segment Information, Revenue by

Segment Information, Revenue by Segment (Details) $ in Thousands		3 Months Ended
		Mar. 31, 2020USD ($)Segment	Mar. 31, 2019USD ($)
Segment Information [Abstract]
Number of reportable segments | Segment		9
Number of geographic segments | Segment		7
Revenue by Segment [Abstract]
Revenue		$ 518,028	$ 623,623
Other [Member]
Revenue by Segment [Abstract]
Revenue		773	(1,426)
Operating Segment [Member] | Nu Skin [Member]
Revenue by Segment [Abstract]
Revenue		490,877	594,351
Operating Segment [Member] | Nu Skin [Member] | Mainland China [Member]
Revenue by Segment [Abstract]
Revenue		137,696	208,488
Operating Segment [Member] | Nu Skin [Member] | Americas/Pacific [Member]
Revenue by Segment [Abstract]
Revenue		74,573	86,456
Operating Segment [Member] | Nu Skin [Member] | South Korea [Member]
Revenue by Segment [Abstract]
Revenue		75,719	83,853
Operating Segment [Member] | Nu Skin [Member] | Southeast Asia [Member]
Revenue by Segment [Abstract]
Revenue		69,586	72,495
Operating Segment [Member] | Nu Skin [Member] | Japan [Member]
Revenue by Segment [Abstract]
Revenue		61,300	62,109
Operating Segment [Member] | Nu Skin [Member] | Hong Kong/Taiwan [Member]
Revenue by Segment [Abstract]
Revenue		35,827	40,558
Operating Segment [Member] | Nu Skin [Member] | EMEA [Member]
Revenue by Segment [Abstract]
Revenue		35,403	41,818
Operating Segment [Member] | Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue	[1]	27,147	29,272
Operating Segment [Member] | Grow Tech [Member]
Revenue by Segment [Abstract]
Revenue		4	0
Intersegment Member] | Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue		$ 6,400	$ 5,900
[1]	The Manufacturing segment had $6.4 million and $5.9 million of intersegment revenue for the three-month period ended March 31, 2020 and 2019, respectively.  Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above.

Segment Information, Segment Co

Segment Information, Segment Contribution (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Contribution [Abstract]
Operating income (loss)	$ 36,565	$ 68,653
Other income (expense)	(6,174)	(2,848)
Income before provision for income taxes	30,391	65,805
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income (loss)	106,949	137,794
Operating Segment [Member] | Nu Skin [Member]
Segment Contribution [Abstract]
Operating income (loss)	110,950	137,777
Operating Segment [Member] | Nu Skin [Member] | Mainland China [Member]
Segment Contribution [Abstract]
Operating income (loss)	37,387	59,167
Operating Segment [Member] | Nu Skin [Member] | South Korea [Member]
Segment Contribution [Abstract]
Operating income (loss)	24,099	25,668
Operating Segment [Member] | Nu Skin [Member] | Americas/Pacific [Member]
Segment Contribution [Abstract]
Operating income (loss)	10,585	12,019
Operating Segment [Member] | Nu Skin [Member] | Southeast Asia [Member]
Segment Contribution [Abstract]
Operating income (loss)	16,718	17,992
Operating Segment [Member] | Nu Skin [Member] | Japan [Member]
Segment Contribution [Abstract]
Operating income (loss)	14,592	14,106
Operating Segment [Member] | Nu Skin [Member] | Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income (loss)	6,938	7,474
Operating Segment [Member] | Nu Skin [Member] | EMEA [Member]
Segment Contribution [Abstract]
Operating income (loss)	631	1,351
Operating Segment [Member] | Manufacturing [Member]
Segment Contribution [Abstract]
Operating income (loss)	2,849	3,646
Operating Segment [Member] | Grow Tech [Member]
Segment Contribution [Abstract]
Operating income (loss)	(6,850)	(3,629)
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income (loss)	$ (70,384)	$ (69,141)

Segment Information, Depreciati

Segment Information, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 19,095	$ 19,607
Capital expenditures	19,387	13,765
Operating Segments [Member] | Nu Skin [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	5,582	7,335
Capital expenditures	4,545	2,767
Operating Segments [Member] | Nu Skin [Member] | Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	2,424	3,116
Capital expenditures	2,861	1,681
Operating Segments [Member] | Nu Skin [Member] | South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,057	1,524
Capital expenditures	169	49
Operating Segments [Member] | Nu Skin [Member] | Americas/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	245	214
Capital expenditures	694	274
Operating Segments [Member] | Nu Skin [Member] | Southeast Asia [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	487	477
Capital expenditures	633	94
Operating Segments [Member] | Nu Skin [Member] | Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	472	1,048
Capital expenditures	157	172
Operating Segments [Member] | Nu Skin [Member] | Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	639	516
Capital expenditures	4	463
Operating Segments [Member] | Nu Skin [Member] | EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	258	440
Capital expenditures	27	34
Operating Segments [Member] | Manufacturing [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,815	1,574
Capital expenditures	10,505	1,602
Operating Segments [Member] | Grow Tech [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	1,225	875
Capital expenditures	178	2,985
Corporate and Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	10,473	9,823
Capital expenditures	$ 4,159	$ 6,411

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2018
Restructuring [Abstract]
Non-cash impairment charges			$ 48,600
Cash charges associated with restructuring			22,100
Employee severance			20,100
Other related restructuring charges			2,000
Restructuring Reserve [Roll Forward]
Beginning balance		$ 15,462
Amounts paid		(15,046)
Adjustments		(416)
Ending balance		$ 0	$ 15,462
Restructuring activity	$ 0